Skip to Main Content
Professional Photo
Professionals

Anjana D. Patel

Shareholder

Anjana Patel ("Ahnj-na Puh-tel") is a nationally recognized health care attorney with more than 25 years of experience guiding health care providers, organizations, and investors through complex legal and business challenges. Known for her sharp strategic thinking and deep industry knowledge, Anjana is a trusted advisor to clients navigating today's dynamic health care landscape.

Professional Biography


Her practice focuses on transactional, regulatory, and compliance matters, with a particular emphasis on mergers and acquisitions, joint ventures, affiliations, recapitalizations, consolidations, and physician-alignment strategies. Anjana routinely advises both buy-side and sell-side clients and is especially well-regarded for representing physicians and health care organizations in transactions with private equity sponsors and national strategic companies and partnerships with hospitals and health systems.

Anjana's client roster includes hospitals, health systems, physician and dental practices, ambulatory surgery centers, clinical labs, specialty pharmacies, post-acute care providers, management services organizations (MSOs), revenue cycle management companies, and other health care-adjacent businesses. She frequently works on multi-state transactions and offers nuanced counsel that combines regulatory insight with a clear-eyed understanding of business goals.

In addition to her transactional work, Anjana provides comprehensive guidance on regulatory compliance, including federal and state anti-kickback (AKS) and self-referral laws (Stark), the corporate practice of medicine, fee-splitting laws, licensure, certificate of need (CON) requirements, and internal governance issues for both non-profit and for-profit entities.

A frequent speaker at national and regional industry conferences, Anjana is a recognized thought leader in the health care space. Her insights have been featured in leading health care publications, where she contributes to the ongoing conversation about innovation, compliance, and strategy in a highly regulated environment.

Anjana is the managing shareholder of Baker Donelson's New Jersey offices.

Results may vary depending on your particular facts and legal circumstances.

  • Represented a cardiology practice in the mid-Atlantic region in connection with a recapitalization transaction with a private equity sponsor.

  • Represented a large primary care practice located in the mid-Atlantic region in connection with a sale to a payor.

  • Represented a reproductive medicine practice in connection with a recapitalization transaction with a private equity sponsor.

  • Represented a radiology services provider in connection with a sale of its outpatient imaging centers to a private equity sponsor.

  • Represented a cardiology practice and its office-based labs and ambulatory surgery centers in connection with a sale to regional health system.

  • Represented a specialty pharmacy company in connection with a sale to a private equity sponsor.

  • Represented an ear, nose, throat, and allergy practice in connection with a recapitalization transaction with a private equity sponsor.

  • Represented a private-equity-backed portfolio company in connection with acquiring physician practices specializing in ear, nose, throat, and allergy services.

  • Served as counsel to a dental services management company in connection with the acquisition of oral surgery practices.

  • Represented a regional home health care services company in connection with a sale to a national company.

  • Served as transactional and regulatory counsel to a large ear, nose, and throat practice, in connection with forming a management services organization and a strategic partnership with a financial partner.

  • Served as counsel to a regional laboratory company in connection with a sale to a strategic partner.

  • Represented a large dental services practice with multiple locations in the Northeast in connection with a sale to a private equity sponsor.

  • Represented a large primary care practice in connection with a sale to a national strategic company.

  • Assisted a large health system in connection with its acquisition of a community-based hospital.

  • Represented a large regional home health care services company in connection with its add-on acquisitions of home and personal care services companies in New Jersey, Connecticut, and Pennsylvania.

  • Represented a major health system in connection with an outsourcing agreement involving its inpatient hospital labs.

  • Represented a regional imaging company in connection with imaging center acquisitions in New York, New Jersey, and Pennsylvania.

  • Served as transactional and regulatory counsel to a large dermatology practice in the Northeast, with multiple clinical offices located in Massachusetts and New Hampshire, in connection with a strategic partnership with, and growth investment by, one of the largest private equity firms focusing on the physicians' service sector.

  • Served as transactional and regulatory counsel to a large multidisciplinary medical group with more than 40 practice locations in the Northeast (including urgent care centers) in an acquisition by Optum (and its affiliates) as well as several add-on acquisitions over the following year.

  • Served as counsel to a large Federally Qualified Health Center (FQHC) in connection with transactional and regulatory matters.

  • Served as counsel to a large retina practice in connection with a recapitalization transaction with a private equity sponsor.

  • Represented a West Coast-based specialty pharmacy in connection with a sale to CVS.

  • Represented a Midwest-based health system in connection with a joint venture for behavioral health services with a national company.

  • Served as transactional and regulatory counsel to a middle-market private equity fund on the acquisition of a major home health company operating in two states followed by several add-on acquisitions of home health companies and offices in 15 states as part of further national growth of the company.

  • Represented multiple physician groups in major physician alignment transactions with various health systems in New Jersey.

  • Served as transactional and regulatory counsel to a large health care New Jersey health system, including in connection with an affiliation transaction with a Pennsylvania university and health system.

  • Represented a local health system in connection with a divestiture of one of its hospital subsidiaries to a for-profit company.

  • Represented multiple physician groups in connection with mergers and asset or stock purchase transactions.

  • Represented a multispecialty ambulatory surgery center in connection with a sale to a large regional ambulatory surgery center operator.

No aspect of this advertisement has been approved by the Supreme Court of New Jersey.

  • Listed in The Best Lawyers in America® for Health Care Law (2011 – 2025). This award is conferred by Best Lawyers. A description of the selection methodology is available here.
  • Name the Best Lawyers® 2021 "Lawyer of the Year" for Health Care Law in Newark. This award is conferred by Best Lawyers. A description of the selection methodology is available here.
  • Selected to Chambers USA as a leading Health Care lawyer in New Jersey (2010 – 2024). This award is conferred by Chambers and Partners. A description of the selection methodology is available here.
  • Recommended by The Legal 500 United States for M&A: Middle Market (Sub-$500 Million) (2019, 2022, 2024). This award is conferred by The Legal 500. A description of the selection methodology is available here.
  • Listed in New Jersey Super Lawyers for Health Care (2012 – 2025). This award is conferred by Thomson Reuters. A description of the selection methodology is available here.
  • Recipient – New Jersey Law Journal's Professional Excellence Award: Dealmakers (2020). This award is conferred by the New Jersey Law Journal. A description of the selection methodology is available here.
  • Listed in New Jersey Rising Stars for Health Care (2008 – 2009, 2011). This award is conferred by Thomson Reuters. A description of the selection methodology is available here.
  • Selected to New Jersey Law Journal's® "40 Under 40" list (2007). This award is conferred by the New Jersey Law Journal. A description of the selection methodology is available here.
  • Recipient – Asian Pacific American Lawyers Association of New Jersey, Inc. Award in Recognition of Professional Achievement (April 2007). This award is conferred by the Asian Pacific American Lawyers Association of New Jersey, Inc. 
  • Member – Springpoint Senior Living, Board of Trustees
  • Member – Law360 Mergers & Acquisitions Advisory Board (2024)
  • Member – Intealth, Audit, Compliance, and Q&A Committee
  • Faculty Member – The Governance Institute
  • Member – American Health Law Association, Physicians and Hospitals Law Institute Program Planning Committee (former)
  • Member – American Bar Association, Health Law Forum
  • Member – New Jersey State Bar Association, Health and Hospital Law Section
  • "How Cardiology Groups Are Valued and How to Maximize Practice Value by Getting Your House in Order," 2025 Physician Transactions Conference: Cardiology, The Future of Healthcare Conference Series® (March 2025)
  • "How Orthopedic & Spine Groups Are Valued and How to Maximize Practice Value by Getting Your House in Order," 2025 Physician Transactions Conference: Orthopedic & Spine, The Future of Healthcare Conference Series® (March 2025)
  • "Private Equity in Healthcare," Withum's Healthcare Symposium 2024 (December 2024)
  • "The Intersection of PE and MSOs, Part 1: Benefits and Pre-Transaction Considerations," CV Transforum Fall '24 Conference (October 2024)
  • "Maximizing Value and Protecting Physicians in Strategic Partnerships," MedAxiom, an American College of Cardiology Company (September 2024)
  • 2024 Physician Transactions Conference, The Future of Healthcare Conference Series™ (February 2024)
  • "Healthcare Mergers, Acquisitions, and Affiliations," Withum 2023 Healthcare Symposium (December 2023)
  • "How to Maximize Your Practice's Value by 'Getting Your House in Order'," Orthopaedic Summit 2023 (September 2023)
  • "Private Equity Physician Deals: What Investors, Physicians, and Hospitals Need to Know in 2023," American Health Law Association (AHLA) Health Care Transactions 2023 Conference (April 2023)
  • "The Anatomy of a Private Equity Transaction and Process," 6th Annual Physician Transactions Conference: The Future of Healthcare Conference Series™ (March 2023)
  • "Healthcare Mergers, Acquisitions, and Affiliations," Withum 2022 Healthcare Symposium (December 2022)
  • "The Anatomy of a Physician Group Transaction with Private Equity," 2022 Physician Transactions Conference (March 2022)
  • "Breaking Down 'Bro' Culture: Cultivating Male Allies & Change Agents," CenterForce USA Women, Diversity, & Change on Wall Street Virtual Summit (October 2021)
  • "The Process of Undergoing a Strategic Medical Practice Transaction," 2021 Physician Transactions Conference (April 2021)
  • "Assessing Strategic Options and Practice Value in the Wake of the Pandemic," 2021 Physician Transactions Conference (April 2021)
  • "Healthcare Mergers & Acquisitions in the Wake of COVID-19," Denver Medical Study Group (March 2021)
  • "Contract Negotiations for the Young Arthroplasty Surgeon," American Association of Hip and Knee Surgeons (AAHKS) Fellows Orthopaedic Continued AAHKS Learning (FOCAL) Committee (November 2020)
  • "Exit Planning and Strategic Transactions for Physician Groups," AllianceBernstein (June 2020)
  • "Part 3: The Transaction Process, Key Protections for Physicians, and How to Prepare," Physician Group Transactions 2020 (May 2020)
  • "Part 2: Beyond the First Partnership – Second Bites and More," Physician Group Transactions 2020 (April 2020)
  • "Part 1: What's Going On, and What Do You Need to Know?," Physician Group Transactions 2020 (April 2020)
  • "Alternatives to Hospital Mergers," Physicians and Hospitals Law Institute (February 2020)
  • "Physician Group Strategic Transactions on the Rise," The Future of Health Care Conference Series (April 2019)

Email Disclaimer

NOTICE: The mailing of this email is not intended to create, and receipt of it does not constitute an attorney-client relationship. Anything that you send to anyone at our Firm will not be confidential or privileged unless we have agreed to represent you. If you send this email, you confirm that you have read and understand this notice.
Cancel Accept